Maynard Um
-
-
-
-
-
-
-
CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
-
-
-
-
-
-
-
OSR Holdings acquires VXM01 intellectual property for $30 million
-
-
-
-
-
-
-
OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe
-
-
-
-
-
-
-
OSR Holdings unit signs NDA with China's Sinopharm for glucose tech
-
-
-
-
-
-
-
OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries
-
-
-
-
-
-
-
OSR Holdings issues 2.3 million shares under structured financing
-
-
-
-
-
-
-
OSR Holdings (OSRH) Appoints Constance Höfer as Chief Scientific Officer
436,412 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

